Texas Would Study Psilocybin And MDMA To Treat PTSD And Depression Under New Bill

A Texas lawmaker introduced a bill on Wednesday that would require the state to study the therapeutic potential of psilocybin, MDMA and ketamine in the treatment of certain mental health conditions.

The legislation from Rep. Alex Dominguez (D) would mandate that the Department of State Health Services conduct the study in collaboration with the Texas Medical Board and report on its findings by December 1, 2022.

Researchers should “evaluate and determine whether alternative therapies are effective in treating the mental health and other medical conditions” such as depression, anxiety, post-traumatic stress disorder, bipolar disorder, chronic pain and migraines, the text of the bill, HB 1802, states.